The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives

Trends Cardiovasc Med. 2007 Nov;17(8):275-83. doi: 10.1016/j.tcm.2007.09.005.

Abstract

Interest in the biology of white adipose tissue has increased dramatically since the discovery of leptin in 1994. The identification of the product of the gene obese (ob) threw light on the role of adipose tissue in the physiopathology of obesity-related diseases and spurred the identification of numerous other adipokines, many of a proinflammatory nature. It has become increasingly evident that white adipose tissue-derived cytokines mediate between obesity-related exogenous factors (nutrition and lifestyle) and the molecular events that lead to metabolic syndrome, inflammation, and cardiovascular diseases. Here we review recent adipokine research, with particular attention to the roles of adiponectin, leptin, resistin, visfatin, apelin, omentin, and chemerin in such conditions.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adipokines*
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / physiopathology*
  • Cardiovascular System*
  • Chemokines
  • Cytokines
  • Humans
  • Leptin
  • Nicotinamide Phosphoribosyltransferase
  • Obesity / complications*
  • Obesity / physiopathology
  • Resistin

Substances

  • Adipokines
  • Chemokines
  • Cytokines
  • Leptin
  • Resistin
  • Nicotinamide Phosphoribosyltransferase